Product Information

BUPROPION HCL XL 150 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0782 per EA under NDC 00904750561. Its NADAC has been published 86 times since Mar 26, 2025.

FDA first approved this application on Apr 6, 2017. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUPROPION HCL XL 150 MG TABLET

Bupropion Hydrochloride
$0.0782per EA

Strength

150 mg/1

NDC

00904750561

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

BUPROPION HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA090693

FDA Approved

4/6/2017

TE Code

AB3

On Market Since

11/25/2024

Pharmacological Classes

Aminoketone
Dopamine Uptake Inhibitors
Increased Dopamine Activity
Increased Norepinephrine Activity
Norepinephrine Uptake Inhibitors

Price Statistics

The NADAC for BUPROPION HCL XL 150 MG TABLET has been published 86 times since Mar 26, 2025, and over the history we have for it it has declined 26.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0782 per EA
All-time high$0.1059 (Apr 16, 2025)
All-time low$0.0770 (Apr 22, 2026)
52-week high$0.0943
52-week low$0.0770
Median price$0.0866
Average price$0.0895
Largest weekly change-8.4% (Feb 18, 2026)
Weeks tracked86
Tracking sinceMar 26, 2025

Price History

1W

0.0%

1M

-0.4%

3M

+0.5%

6M

+1.6%

1Y

-18.9%

3Y

N/A

5Y

N/A

All

-26.2%

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUPROPION HCL XL 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL XL 150 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0782 per EA (NDC 00904750561), effective Nov 11, 2026.

How has the price of BUPROPION HCL XL 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUPROPION HCL XL 150 MG TABLET has declined 26.2%. It has been tracked across 86 weekly CMS publications since Mar 26, 2025.

What are the highest and lowest recorded NADAC prices for BUPROPION HCL XL 150 MG TABLET?

Since Mar 26, 2025, the NADAC for BUPROPION HCL XL 150 MG TABLET has ranged from a low of $0.0770 (Apr 22, 2026) to a high of $0.1059 (Apr 16, 2025), with a median of $0.0866 per EA.

Are there cheaper alternatives to BUPROPION HCL XL 150 MG TABLET?

11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPROPION HCL XL 150 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BUPROPION HCL XL 150 MG TABLET?

BUPROPION HCL XL 150 MG TABLET (NDC 00904750561) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.